Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015
Medication labelWhy this: Advisory · dailymed-prescription
REXULTI is indicated for: Adjunctive treatment to antidepressants for major depressive disorder (MDD) in adults Treatment of schizophrenia in adults and pediatric patients ages 13 years and older Treatment of agitation associated with dementia due to Alzheimer's disease Limitations of Use: REXULTI is not indicated as an as needed ("prn") treatment for agitation associated with dementia due to Alzheimer's disease [see Clinical Studies (14.3)].
- generic_name
- brexpiprazole
- product_names
- brexpiprazole, BREXPIPRAZOLE
- ndc
- 59148-035, 59148-035-13, 59148-036, 59148-036-13, 59148-036-07, 59148-037, 59148-037-13, 59148-037-07, 59148-038, 59148-038-13, 59148-038-07, 59148-039, 59148-039-13, 59148-039-07, 59148-040, 59148-040-13, 59148-040-07, 59148-044, 59148-044-14, 59148-042, 59148-042-07
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en